Haemophilus influenzae type b immunization in infants in the United Kingdom: Effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose

Pediatrics

Volumn 117, Issue 4, 2006, Pages

  Berrington, Janet E ^a   Cant, Andrew J ^b   Matthews, John N S ^c   O'Keeffe, Marilyn ^c   Spickett, Gavin P ^a   Fenton, Alan C ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acellular; Booster; Haemophilus influenzae type b; Immunization; Preterm

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HEMOPHILUS INFLUENZAE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; NEIS VAC C; PNEUMOCOCCUS VACCINE; POLYRIBOSYLRIBITOLPHOSPHATE ANTIBODY; TETANUS TOXOID ANTIBODY; UNCLASSIFIED DRUG; VACCINE; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZA TYPE B POLYSACCHARIDE VACCINE TETANUS TOXIN CONJUGATE; HAEMOPHILUS INFLUENZA TYPE B POLYSACCHARIDE VACCINE-TETANUS TOXIN CONJUGATE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE; POLYRIBITOL PHOSPHATE; POLYSACCHARIDE; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DOSE RESPONSE; DRUG EFFECT; HUMAN; IMMUNIZATION; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PERTUSSIS; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; SINGLE DRUG DOSE; STREPTOCOCCUS INFECTION; TETANUS; UNITED KINGDOM; BACTERIAL INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNOLOGY; NEWBORN;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; IMMUNIZATION, SECONDARY; INFANT, NEWBORN; INFANT, PREMATURE; POLYSACCHARIDES; POLYSACCHARIDES, BACTERIAL; TETANUS TOXOID; VACCINES, COMBINED; VACCINES, CONJUGATE;

EID: 33646350017     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0348     Document Type: Article

References (29)

1. Ramsay ME, McVernon J, Andrews NJ, et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis. 2003;188: 481-485
2. Department of Health. Immunisation Against Infectious Diseases. London, England: HMSO; 1996
3. Booy R, Taylor SA, Dobson SR, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child. 1992;67: 475-478
4. Booy R, Hodgson S, Carpenter L, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet. 1994;344: 362-366
5. Steinhoff M, Goldblatt D. Conjugate Hib vaccines. Lancet. 2003; 361:360-361
6. Begg N, Miller E, Fairley CK, et al. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection. Vaccine. 1995;13: 1547-1550
7. Bell F, Martin A, Blondeau C, et al. Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation. Arch Dis Child. 1996;75:298-303
8. Goldblatt D, Miller E, McCloskey N, Cartwright K. Immunological response to conjugate vaccines in infants: follow up study. BMJ. 1998;316:1569-1570
9. Bell F, Heath P, Shackley F, et al. Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T). Vaccine. 1998;16:637-642
10. Goldblatt D, Richmond P, Millard E, Thornton C, Miller E. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis. 1999;180:538-541
11. McVernon J, Andrews N, Slack MPE, Ramsay ME. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet. 2003;361: 1521-1523
12. Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis. 2000;31: 973-980
13. Heath PT, Booy R, McVernon J, et al. Hib vaccination in infants born prematurely. Arch Dis Child. 2003;88:206-210
14. Slack MH, Schapira D, Thwaites RJ, et al. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis. 2001;184: 1617-1620
15. Robinson MJ, Campbell F, Powell P, Sims D, Thornton C. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 1999;80:F69-F71
16. Clarke P, Powell P, Goldblatt D, Robinson M. Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease. Arch Dis Child. 2003;88(suppl 1):58-61
17. Slack MH, Schapira, C, Thwaites RJ, et al. Responses to a fourth dose of Haemophilus influenzae type b conjugate vaccine in early life. Arch Dis Child Fetal Neonatal Ed. 2004;89: F269-F271
18. Stata Statistical Software [computer program]. Release 7.0. College Station, TX: Stata Corp; 2001
19. Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods. 1990;135: 121-128
20. Kristensen K, Gyhrs A, Lausen BF, Barington T, Heilmann C. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J. 1996;15:525-529
21. Heath PT, Bowen-Morris J, Griffiths D, Griffiths H, Crook DWM, Moxon E. Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T. Arch Dis Child. 1997;77:488-492
22. Käyhty H. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. Biologicals. 1994;22:397-402
23. Granoff DM. Assessing efficacy of Haemophilus influenzae type b combination vaccines. Clin Infect Dis. 2001;33(suppl 4): S278-S287
24. Alexander H, Heidelberger M, Leidy G. The protective or curative element in type b H. influenzae rabbit serum. Yale J Biol Med. 1944;16:425-440
25. Fothergill LD, Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol. 1933;24:273-284
26. Peltola H, Käyhty H, Sivonen A, Makela PH. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977;60:730-737
27. Käyhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983;147:1100
28. Department of Health. Professional letter 17th February 2003. PL/CMO/2003/1, PL/CNO/2003/2, PL/CPHO/2003/1. London, United Kingdom
29. Rijkers GT, Vermeer-de Bondt P, Spanjaard L, Breukels MA, Sanders EA. Return of Haemophilus influenzae type b infections. Lancet. 2003;361:1563-1564